Trial reportScientific reports2025
Rhythm training improves word-reading in children with dyslexia.
Trial report in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05154721 (Effect of Music and Rhythm Training Delivered Through a Serious Game on the Reading Skills of Children With a Specific Learning Disorder Impacting Reading, a Multicentric Double-blind and Placebo-controlled Study), which is not on this map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effect of Music and Rhythm Training Delivered Through a Serious Game on the Reading Skills of Children With a Specific Learning Disorder Impacting Reading, a Multicentric Double-blind and Placebo-controlled Study (Mila-Learn-01)
Who cites it
3 citing papers in PubMed.
- The Use of EEG in the Study of Emotional States and Visual Word Recognition with or Without Musical Stimulus in University Students with Dyslexia.Brain sciences · 2026Article
- Children's Improvement After Language and Rhythm Training With the Digital Medical Device Poppins for Dyslexia: Single-Arm Intervention Study.JMIR serious games · 2025Article
- Enhancing text-level reading fluency and engagement in immigrant children through a structured singing-based intervention.Frontiers in psychology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Specific learning disorder with reading deficit (SLD-reading), or dyslexia, is one of the most common neurodevelopmental disorders. Intensive training with reading specialists is recommended, but delayed access to care is common. In this study, we tested an innovative user-friendly and accessible intervention, the medical device Mila-Learn, which is a video game based on cognitive and rhythmic training to improve phonological and reading ability. This randomized placebo-controlled trial (ClinicalTrials.gov NCT05154721) included children aged 7 to 11 y/o with SLD-reading. The children were in 2nd to 5th grade and had been in school for more than 3 years. The exclusion criteria were reading or writing remediation during the past 12 months, previous use of Mila-Learn, and severe chronic illness. The patients, who were all native French speakers, were recruited from throughout France and were randomly assigned to Mila-Learn or a matched-placebo game for an 8-week training. The primary variable was nonword decoding. The secondary variables included phonological skills, 2-min word-reading accuracy and speed, grapheme-to-phoneme conversion skills, and self-esteem. Between September 2021 and April 2023, 151 children were assigned to Mila-Learn (n = 75; male = 36; female = 39) or the placebo (n = 76; male = 42; female = 34). We registered 39 adverse events; only one was due to the protocol and was in the placebo group. We found no differences between the groups in nonword decoding in the intention-to-treat (N = 151; p = 0.39) or per-protocol analysis (N = 93; p = 0.21). However, the per-protocol analysis revealed the superiority of Mila-Learn over the placebo by 5.05 score points (95% CI 0.21; 10.3, p < 0.05) for 2-minute word-reading accuracy and by 5.44 score points (95% CI 0.57; 10.99, p < 0.05) for 2-min word-reading speed. We found no other significant effects. Mila-Learn is safe for children with SLD-reading who might benefit from this medical device.Study registration: ClinicalTrials.gov NCT05154721-13/12/2021.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.